<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="216544">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00266084</url>
  </required_header>
  <id_info>
    <org_study_id>02-00-16</org_study_id>
    <nct_id>NCT00266084</nct_id>
  </id_info>
  <brief_title>Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix</brief_title>
  <official_title>Double-Blinded Multicenter Clinical Study Assessing the Equivalence of the InPath Cervical Cell Collector to the Standard Endocervical Brush and Spatula in Patients Seeking Primary Pap Screening or Follow-up Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <brief_summary>
    <textblock>
      This study tested the safety and performance of a new cell collector device and compared the
      results to those obtained with the current existing device that are being used routinely
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study tested the feasibility, safety and efficacy of the new e2TM Collector, and
      compared its performance with the standard method for obtaining cervical cells for Pap test
      of endocervical cytobrush and Ayer's Spatula
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 1999</start_date>
  <completion_date>November 2001</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_groups>1</number_of_groups>
  <enrollment>85</enrollment>
  <condition>Uterine Cervical Dysplasia</condition>
  <condition>Uterine Cervical Intraepithelial Neoplasia</condition>
  <condition>Uterine Cervical Neoplasia</condition>
  <condition>Uterine Cervical Cancer</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Women ages &gt;14 being followed for a previous abnormal Pap All patients will have signed an
        Informed Consent form prior to being enrolled in this study

        Exclusion Criteria:

        Patients who have had a hysterectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George I Gorodeski, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals of Cleveland, Case Western Reserve University</affiliation>
  </overall_official>
  <verification_date>November 2001</verification_date>
  <lastchanged_date>May 10, 2016</lastchanged_date>
  <firstreceived_date>December 14, 2005</firstreceived_date>
  <keyword>Cervix</keyword>
  <keyword>Uterus</keyword>
  <keyword>Dysplasia</keyword>
  <keyword>Cancer</keyword>
  <keyword>Collector</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
    <mesh_term>Uterine Cervical Dysplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
